Anavex Life Sciences Corp (AVXL)

[raja48185]

Recent WSJ article said there was little support for aducanumab from AD advocacy groups, given the ambiguous trial results, the SAEs, and past disappointment with the plaque MOA. Not sure how true this is, but was interesting to read. Public opinion, if strong enough, can have a small but real effect on FDA final assessments. Looks like it won't be a factor with Biogen's drug.

The press has to make it interesting enough so that people read the articles. That is the their job. Otherwise it does not make any logical or business sense. There is no conspiracy or boogeyman involved.

There is no cabal inside the FDA that can be influenced and they are not going to be swayed by public opinion,given that it is an independent body with enough qualified people to make decisions. They look at data first and foremost. To a rank outsider, what looks like it won't happen, may happen and vice versa. This is about drug companies and it takes patience and not about making assumptions.